First Results Out for Off-the-Shelf CAR-T Therapy in Solid Tumors
The Belgian company Celyad has released the first interim clinical efficacy data for an off-the-shelf…
The Belgian company Celyad has released the first interim clinical efficacy data for an off-the-shelf…
Based in Cambridge, UK, Lightcast Discovery is developing microfluidics technology that automates cell screening experiments…
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
The UK biotech Autolus’ shares have slumped as construction delays from a new manufacturing site…
As an important part of the adaptive immune system, T cells play an essential role…
A new wave of therapies based on a unique type of immune cells, called gamma…
European biotech companies gathered in Chicago, USA, to share the latest advances in cancer research…
The diagnostics company Biocartis is collaborating with Kite Pharma to monitor the progress of CAR…
In biotechnology, plasmids are commonly used as vectors for the replication and cloning of recombinant…
Cell Medica’s next-generation CAR-T cell therapy has resulted in 'extensive tumor regression' in a…
The UK biotech Cell Medica has received a €7.6M ($8.7M) grant from the Cancer Prevention…
With this year coming to a close, it’s now time to look back at the…